Companies
why BridgeBio Pharma Inc [BBIO] is a Good Choice for Investors After New Price Target of $48.10
BridgeBio Pharma Inc [NASDAQ: BBIO] loss -0.51% or -0.15 points to close at $29.45 with a heavy trading volume of 4750725 shares. The company report on March 5, 2024 at 11:53 PM that BridgeBio Pharma Announces Pricing of Public Offering of Common Stock. J.P. Morgan,
